PT UBC Medical Indonesia Tbk (ISX:LABS) Research & Development: Rp Mil (TTM As of . 20)


What is PT UBC Medical Indonesia Tbk Research & Development?

PT UBC Medical Indonesia Tbk ISX:LABS -0.71% Research & Development is Rp Mil as of . 20. The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. PT UBC Medical Indonesia Tbk's Research & Development for the six months ended in . 20 was Rp0.00 Mil. PT UBC Medical Indonesia Tbk does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in . 20.

PT UBC Medical Indonesia Tbk  (ISX:LABS) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

PT UBC Medical Indonesia Tbk Research & Development Related Terms

PT UBC Medical Indonesia Tbk Research & Development Historical Data

* Premium members only.

The historical data trend for PT UBC Medical Indonesia Tbk's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT UBC Medical Indonesia Tbk Research & Development Chart

PT UBC Medical Indonesia Tbk Annual Data
Trend
Research & Development

PT UBC Medical Indonesia Tbk Semi-Annual Data
Research & Development

PT UBC Medical Indonesia Tbk Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of Rp Mil mean?
PT UBC Medical Indonesia Tbk (ISX:LABS) has a Research & Development of Rp Mil as of . 20. Research and development expense is the total cost for research and development activities. View historical data on PT UBC Medical Indonesia Tbk and its competitors.
Is PT UBC Medical Indonesia Tbk's Research & Development too high?
PT UBC Medical Indonesia Tbk's current Research & Development is Rp Mil.
How does PT UBC Medical Indonesia Tbk's Research & Development compare to ABT and SYK?
PT UBC Medical Indonesia Tbk's Research & Development of Rp Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on PT UBC Medical Indonesia Tbk and its competitors. PT UBC Medical Indonesia Tbk's current Research & Development is Rp Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT UBC Medical Indonesia Tbk stock overvalued right now?
PT UBC Medical Indonesia Tbk (ISX:LABS) has a current Research & Development of Rp Mil. The current Research & Development is Rp Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For PT UBC Medical Indonesia Tbk (ISX:LABS), the current Research & Development is Rp Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PT UBC Medical Indonesia Tbk Business Description

Address Jl. Rawagelam V, Blok L, No Kav 11-13, Kantor Pusat, Kawasan Industri Pulogadung, Kel. Jatinegara Kec. Cakung, Jakarta Timur, Jakarta, IDN
PT UBC Medical Indonesia Tbk is a distribution company. It engages in wholesale of Laboratory Equipment, Pharmaceutical Equipment, and Medical Equipment for Humans and animals, which includes the wholesale of laboratory equipment, pharmaceutical equipment, and medical equipment. It divides its main marketed medical equipment products into two categories Instruments, in the form of equipment, machines, and analyzers, are used in laboratories. The function of instruments is to process specimens or biological samples to measure and examine the levels of certain substances/contents; and Consumables include single-use medical devices used for treatment or health examinations and Reagents include chemical reagents used in laboratory tests to detect, measure, examine, & produce other substances.